Apport des auto-anticorps au cours des myopathies auto-immunes

Amato, 2003, Unicorns, dragons, polymyositis, and other mythological beasts, Neurology, 61, 288, 10.1212/WNL.61.3.288 Benveniste, 2011, Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy, Arthritis Rheum, 63, 1961, 10.1002/art.30344 Benveniste, 2011, Myositis or dystrophy? Traps and pitfalls, Presse Med, 40, e249, 10.1016/j.lpm.2010.11.023 Betteridge, 2009, Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis, Ann Rheum Dis, 68, 1621, 10.1136/ard.2008.097162 Brouwer, 2001, Autoantibody profiles in the sera of European patients with myositis, Ann Rheum Dis, 60, 116, 10.1136/ard.60.2.116 Casciola-Rosen, 2005, Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy, J Exp Med, 201, 591, 10.1084/jem.20041367 Chinoy, 2007, The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis, Ann Rheum Dis, 66, 1345, 10.1136/ard.2006.068502 Christopher-Stine, 2010, A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy, Arthritis Rheum, 62, 2757, 10.1002/art.27572 Espada, 2009, Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein, J Rheumatol, 36, 2547, 10.3899/jrheum.090461 Fujimoto, 2012, Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins, Arthritis Rheum, 64, 513, 10.1002/art.33403 Ghirardello, 2006, Clinical implications of autoantibody screening in patients with autoimmune myositis, Autoimmunity, 39, 217, 10.1080/08916930600622645 Grable-Esposito, 2010, Immune-mediated necrotizing myopathy associated with statins, Muscle Nerve, 41, 185, 10.1002/mus.21486 Hamaguchi, 2011, Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study, Arch Dermatol, 147, 391, 10.1001/archdermatol.2011.52 Hausmanowa-Petrusewicz, 1997, Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies, Arthritis Rheum, 40, 1257, 10.1002/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R Hengstman, 2006, Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy, Ann Rheum Dis, 65, 1635, 10.1136/ard.2006.052191 Hervier, 2012, Hierarchical cluster anlyses of anti-synthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity, Autoimmun Rev, 12, 210, 10.1016/j.autrev.2012.06.006 Hoogendijk, 2004, 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands, Neuromuscul Disord, 14, 337, 10.1016/j.nmd.2004.02.006 Ichimura, 2012, Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy, Ann Rheum Dis, 71, 710, 10.1136/annrheumdis-2011-200697 Kaji, 2007, Identification of a novel autoantibody reactive with 155 and 140kDa nuclear proteins in patients with dermatomyositis: an association with malignancy, Rheumatology (Oxford), 46, 25, 10.1093/rheumatology/kel161 Kao, 2004, Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy, Arthritis Rheum, 50, 209, 10.1002/art.11484 Koenig, 2007, Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes, Arthritis Res Ther, 9, R78, 10.1186/ar2276 Liang, 2011, Necrotizing autoimmune myopathy, Curr Opin Rheumatol, 23, 612, 10.1097/BOR.0b013e32834b324b Love, 1991, A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups, Medicine (Baltimore), 70, 360, 10.1097/00005792-199111000-00002 Madan, 2009, Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology, Clin Exp Dermatol, 34, 561, 10.1111/j.1365-2230.2009.03227.x Maeda, 2012, Inflammatory myopathies associated with anti-mitochondrial antibodies, Brain, 135, 1767, 10.1093/brain/aws106 Mammen, 2011, Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy, Arthritis Rheum, 63, 713, 10.1002/art.30156 Mammen, 2012, Anti-HMG-CoA reductase antibodies are rare in statin users, including those with self-limited musculoskeletal side-effects, Arthritis Care Res (Hoboken), 64, 269, 10.1002/acr.20662 Miller, 2002, Myopathy with antibodies to the signal recognition particle: clinical and pathological features, J Neurol Neurosurg Psychiatry, 73, 420, 10.1136/jnnp.73.4.420 Mozaffar, 2000, Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres, J Neurol Neurosurg Psychiatry, 68, 472, 10.1136/jnnp.68.4.472 Muro, 2012, Clinical features of anti-TIF1-alpha antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-gamma or anti-Mi-2 autoantibodies, Rheumatology (Oxford), 51, 1508, 10.1093/rheumatology/kes073 Salajegheh, 2011, Autoantibodies against a 43 KDa muscle protein in inclusion body myositis, PLoS One, 6, e20266, 10.1371/journal.pone.0020266 Schmidt, 2000, Clinical and serological aspects of patients with anti-Jo-1 antibodies – an evolving spectrum of disease manifestations, Clin Rheumatol, 19, 371, 10.1007/s100670070030 Stanciu, 2012, Anti-synthetase syndrome with Anti-Jo1 antibodies in 48 patients: pulmonary involvement is predictive of disease-modifying antirheumatic drugs use, J Rheumatol, 39, 1835, 10.3899/jrheum.111604 Suzuki, 2012, Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome, Arch Neurol, 69, 728, 10.1001/archneurol.2011.1728 Targoff, 2006, A novel autoantibody to a 155-kd protein is associated with dermatomyositis, Arthritis Rheum, 54, 3682, 10.1002/art.22164 Targoff, 1985, The association between Mi-2 antibodies and dermatomyositis, Arthritis Rheum, 28, 796, 10.1002/art.1780280711 Tillie-Leblond, 2008, Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset, Thorax, 63, 53, 10.1136/thx.2006.069237 Troyanov, 2005, Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients, Medicine (Baltimore), 84, 231, 10.1097/01.md.0000173991.74008.b0 Werner, 2012, Antibody levels correlate with creatine kinase levels and strength in anti-HMG-CoA reductase-associated autoimmune myopathy, Arthritis Rheum, 64, 4087, 10.1002/art.34673